Are high prices turning new cancer medicines into unfulfilled promises?
The development of innovative new cancer medicines that meaningfully improve patient survival and quality of life is to be celebrated. But a new commentary from Common Sense Oncology published in The Lancet Oncology warns that spiraling prices risk turning these new treatments into unfulfilled promises, because they may not be accessible to the patients who […]
ASCO 2026: Important Trials from ASCO
Common Sense Oncology believes that the design, analysis, and reporting of cancer clinical trials should always be aligned with the outcomes that matter most, and help ensure that new treatments deliver meaningful benefits for patients. ASCO 2026 delivered a compelling mix of breakthrough science, practice-changing insights, and important reality checks, underscoring both the progress and […]